About Index Trending news
Analyze
Top 50 Pricing
Syndax

Syndax

Syndax

Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Debt financing
$4,947,480
Venture capital (Series B)
$26,600,000
Employees

Team size

50+
Xconomy

East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More

Health Stock markets